Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cytomegalovirus Infection

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 37 articles: HTML format

Single Articles

February 2024
1. HAMMOND SP, Little JS
   How much does cytomegalovirus viremia matter after chimeric antigen receptor T-cell therapy?
   Clin Infect Dis. 2024 Feb 2:ciae053. doi: 10.1093.
   PubMed    
   
   
   
2. KAMPOURI E, Boeckh MJ, Hill JA
   Understanding the clinical significance of cytomegalovirus viremia after chimeric antigen receptor T-cell therapy: Should we be treating a value?
   Clin Infect Dis. 2024 Feb 2:ciae030. doi: 10.1093.
   PubMed    
   
   
   January 2024
3. YATES TA, Halliday N
   Re: Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Reci
   Clin Infect Dis. 2024 Jan 9:ciae004. doi: 10.1093.
   PubMed    
   
   
   
4. KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al
   Response to Yates and Halliday regarding CMV DNAemia and time-to-mortality in a Randomized Trial of PET vs AP in CMV D+R-Liver Transplant Recipients.
   Clin Infect Dis. 2024 Jan 8:ciae005. doi: 10.1093.
   PubMed    
   
   
   November 2023
5. PAPANICOLAOU GA, Avery RK, Cordonnier C, Duarte RF, et al
   Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir with Valganciclovir.
   Clin Infect Dis. 2023 Nov 30:ciad709. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. KAMPOURI E, Ibrahimi SS, Xie H, Wong ER, et al
   CMV Reactivation and CMV-Specific Cell-Mediated Immunity after Chimeric Antigen Receptor T-Cell Therapy.
   Clin Infect Dis. 2023 Nov 17:ciad708. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2023
7. KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al
   Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Recipien
   Clin Infect Dis. 2023 Oct 20:ciad643. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2023
8. MANUEL O, Laager M, Hirzel C, Neofytos D, et al
   Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial.
   Clin Infect Dis. 2023 Sep 22:ciad575. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. PORTILLO V, Masouridi-Levrat S, Royston L, Yerly S, et al
   Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients.
   Clin Infect Dis. 2023 Sep 15:ciad550. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2023
10. AMIR J, Chodick G, Pardo J
    Revised protocol for secondary prevention of congenital cytomegalovirus infection with valaciclovir following infection in early pregnancy.
    Clin Infect Dis. 2023 May 9:ciad230. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2023
11. PLOTKIN SA
    Can We Prevent Congenital Infection By Cytomegalovirus?
    Clin Infect Dis. 2023 Mar 28:ciad179. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2023
12. LEVI LI, Molina JM
    Cytomegalovirus (CMV) viremia in people with Human Immunodeficiency Virus (HIV): should we treat the CMV? Or the HIV? or Both?
    Clin Infect Dis. 2023 Jan 10:ciad011. doi: 10.1093.
    PubMed    
    
    
    
13. 
    Correction to: Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
    Clin Infect Dis. 2023 Jan 6:ciac970. doi: 10.1093.
    PubMed    
    
    
    December 2022
14. FANG MZ, Jackson SS, Pfeiffer RM, Kim EY, et al
    No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.
    Clin Infect Dis. 2022 Dec 27:ciac447. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2022
15. FANG M, Lin X, Wang C, Yang X, et al
    High cytomegalovirus viral load is associated with 182-day all-cause mortality in hospitalized people with human immunodeficiency virus (PWH).
    Clin Infect Dis. 2022 Nov 14. pii: 6827090. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
16. SCHNITTMAN SR, Lu MT, Mayrhofer T, Burdo TH, et al
    Cytomegalovirus IgG Titer and Coronary Artery Disease in People with HIV.
    Clin Infect Dis. 2022 Aug 17. pii: 6668874. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. CHEVALIER K, Schmidt J, Coppo P, Galicier L, et al
    Hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection: five cases and a systematic review of the literature.
    Clin Infect Dis. 2022 Aug 17. pii: 6668866. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2022
18. LILLERI D, Tassis B, Pugni L, Ronchi A, et al
    Prevalence, outcome, and prevention of congenital cytomegalovirus infection in neonates born to women with preconception immunity (CHILd study).
    Clin Infect Dis. 2022 Jun 19. pii: 6611487. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
19. ALYSSA FITZPATRICK A, Cooper C, Vasilunas N, Ritchie B, et al
    Describing the impact of maternal hyperimmune globulin and valaciclovir on the outcomes of CMV infection in pregnancy: a systematic review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570695. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2022
20. SU Y, Stern A, Karantoni E, Nawar T, et al
    Impact of letermovir primary Cytomegalovirus (CMV) prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation (HCT): a retrospective cohort study.
    Clin Infect Dis. 2022 Jan 3. pii: 6494526. doi: 10.1093/cid/ciab1064.
    PubMed     Abstract available
    
    
    December 2021
21. AVERY RK, Alain S, Alexander BD, Blumberg EA, et al
    Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial.
    Clin Infect Dis. 2021 Dec 2. pii: 6448443. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2021
22. LANZIERI TM, Kruszon-Moran D, Dollard SM
    Cytomegalovirus seroprevalence among U.S. children 1 to 5 years of age: The National Health and Nutrition Examination Surveys (NHANES), 2017 - March 2020 Pre-pandemic dataset.
    Clin Infect Dis. 2021 Nov 8. pii: 6423497. doi: 10.1093.
    PubMed    
    
    
    July 2021
23. SEMMES EC, Li SH, Hurst JH, Yang Z, et al
    Congenital human cytomegalovirus infection is associated with decreased transplacental IgG transfer efficiency due to maternal hypergammaglobulinemia.
    Clin Infect Dis. 2021 Jul 14. pii: 6321289. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. WAMALWA D, Njuguna I, Maleche-Obimbo E, Begnel E, et al
    Cytomegalovirus viremia and clinical outcomes in Kenyan children diagnosed with HIV in hospital.
    Clin Infect Dis. 2021 Jul 2. pii: 6313248. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
25. PAEZ-VEGA A, Gutierrez-Gutierrez B, Aguera ML, Facundo C, et al
    Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated with Antithymocyte Globulin: A Randomized Clinical Trial.
    Clin Infect Dis. 2021 Jun 22. pii: 6316194. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2021
26. SASSINE J, Khawaja F, Shigle TL, Handy V, et al
    Refractory and Resistant Cytomegalovirus after Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era.
    Clin Infect Dis. 2021 Apr 8. pii: 6217453. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2021
27. WALL N, Godlee A, Geh D, Jones C, et al
    Latent cytomegalovirus infection and previous capsular polysaccharide vaccination predict poor vaccine responses in older adults, independent of chronic kidney disease.
    Clin Infect Dis. 2021 Mar 17. pii: 6174428. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
28. DORFMAN JR, Balla SR, Pathirana J, Groome MJ, et al
    In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection: evidence for boosting but not protection.
    Clin Infect Dis. 2021 Feb 9. pii: 6131727. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2021
29. PEPPA D, Reeves M
    Poor responses to Pneumococcal vaccination in CKD patients - do we need to talk about cytomegalovirus again?
    Clin Infect Dis. 2021 Jan 30. pii: 6124513. doi: 10.1093.
    PubMed    
    
    
    December 2020
30. LANZIERI TM, Kruszon-Moran D, Link-Gelles R, Wong P, et al
    Breastfeeding duration and cytomegalovirus seroprevalence among U.S. children aged 1-5 years: The National Health and Nutrition Examination Surveys, 2011-2012 and 2017-2018.
    Clin Infect Dis. 2020 Dec 30. pii: 6055165. doi: 10.1093/cid/ciaa1900.
    PubMed    
    
    
    
31. AKAHOSHI Y, Kimura SI, Inamoto Y, Seo S, et al
    Effect of cytomegalovirus reactivation with or without acute graft-versus-host disease on the risk of nonrelapse mortality.
    Clin Infect Dis. 2020 Dec 20. pii: 6042338. doi: 10.1093/cid/ciaa1871.
    PubMed     Abstract available
    
    
    
32. PERRY WA, Paulus JK, Price LL, Snydman DR, et al
    Association between lymphopenia at one month post-transplant and infectious outcomes or death in heart transplant recipients.
    Clin Infect Dis. 2020 Dec 6. pii: 6024974. doi: 10.1093/cid/ciaa1800.
    PubMed     Abstract available
    
    
    November 2020
33. HAMEIRI BOWEN D, Sovershaeva E, Charlton B, Schive C, et al
    Cytomegalovirus-Specific Immunoglobulin G is associated with chronic lung disease in children and adolescents from sub-Saharan Africa with perinatal HIV infection.
    Clin Infect Dis. 2020 Nov 26. pii: 6006874. doi: 10.1093/cid/ciaa1757.
    PubMed     Abstract available
    
    
    
34. IMLAY HN, Kaul DR
    Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
    Clin Infect Dis. 2020 Nov 17. pii: 5983750. doi: 10.1093/cid/ciaa1713.
    PubMed     Abstract available
    
    
    March 2020
35. AREND SM, Jedema I
    To Bridge, Blossom, or Boost: That Is the Question.
    Clin Infect Dis. 2020;70:1438-1441.
    PubMed    
    
    
    
36. ZHAO XY, Pei XY, Chang YJ, Yu XX, et al
    First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation.
    Clin Infect Dis. 2020;70:1429-1437.
    PubMed     Abstract available
    
    
    February 2020
37. ROWLAND-JONES S, Yindom LM, Ferrand R
    Reply to Cevik et al.
    Clin Infect Dis. 2020;70:990-991.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.